Skip to main content
. 2015 Jun 30;57(2):129–134. doi: 10.3164/jcbn.15-14

Table 3.

Proportion of patients who reported adequate symptom relief

Placebo group (n = 42) Probiotics group (n = 39) p value
Total, n (%) 26 (61.9) 29 (74.4) 0.230
 IBS-C 5 (83.3) 6 (66.7) 0.604
 IBS-D 12 (52.2) 13 (81.3) 0.063
 IBS-M 6 (66.7) 5 (62.5) 1.0
 IBS-U 3 (75.0) 5 (83.3) 1.0

IBS-C, IBS with constipation; IBS-D, IBS with diarrhea; IBS-M, mixed IBS; IBS-U, un-subtyped IBS.